Monoamine Transporters Genotypes: Risk of PTSD and Related Comorbidities
Status:
Completed
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
Dr. Wang's merit review is aimed at providing a better understanding of the relationship
between SLC6A3/SLC6A4 and the mental health of veterans exposed to high levels of combat
stress, specifically focusing on PTSD symptoms, related co-morbidities, treatment outcomes
and seeks new approaches to therapy for our Veteran population.